ICON announced that its resourcing division, DOCS, has expanded in Europe by opening four new offices: in Milan, Italy; Budapest, Hungary; Brussels, Belgium; and Berlin, Germany. This latest expansion brings the total number of DOCS offices in Europe to 22.
DOCS has been operational in Europe for over 15 years, growing from a small healthcare staffing business to a global provider of resourcing solutions, including functional service provision (FSP), strategic sourcing, and permanent placement. DOCS’ European expansion follows its successful launch in Asia-Pacific in early 2011 and it plans to further expand in other key markets, including Latin America, Eastern Europe, the Middle East, and Russia, in 2012.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Merck Launches Phase III Trials of Once-Monthly Oral HIV PrEP Candidate MK-8527
July 14th 2025In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in sub-Saharan Africa.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.